From @Breakingviews: GSK decided to hive off its unit that makes Advil to concentrate on its remaining pharma business, which mainly makes vaccines for shingles. But a discounted valuation raises the prospect of risky M&A, @aimeedonnellan explains pic.twitter.com/6rsbZT0xdg— Reuters (@Reuters) July 15, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


